Applications are being sought for a joint MGH/Biogen Idec two-year training program in translational neuroscience.
Anne B. Young, MD, PhD, Fellowship in Therapeutic Development 2015 – 2016
Massachusetts General Hospital is pleased to announce that we are accepting applications for a joint MGH/Biogen Idec training program in translational neuroscience. The two-year, clinician scientist program is open to young neurologists who will receive an exceptional training experience for drug development, capitalizing on the expertise of those at Biogen Idec and Mass General. Applications from other institutions are encouraged.
The objective is to train clinician-scientists to rapidly and efficiently translate advances in neuroscience into treatments for people with neurological disorders. The awardee will learn about the entire life cycle of therapy development from industry and academic perspectives. This includes, but is not limited to, therapy selection, biomarker development, trial design and operations and regulatory science. This didactic, hands-on training program will increase the number of clinical investigators who are well trained and passionate about drug development in the neurosciences.
Each awardee will develop a research project under the guidance of a mentoring committee that includes at least one Biogen Idec and one Mass General mentor. Awardees are expected to present their work in regular meetings and to publish results of their research in peer-review journals. Awardees will spend time both at Biogen Idec and Mass General.
The program provides up to 80,000 annual salary support plus fringe benefits. The awardee may receive additional support for course tuition, travel, computer and supplies. Additional support of his/her clinical research project may be available depending on the research project.